Advancing Oncology Trials: Integrating EHR and EDC Systems through eSource Technologies

Session chaired by Mats Sundgren

Description:

Oncology clinical trials are becoming increasingly complex, often generating over 10,000 data points per patient. More than 50% of this data is duplicated between EHRs and research systems, leading to inefficiencies and high verification costs. This session introduces the promise of eSource technologies, particularly EHR-to-EDC integration, as a scalable solution to streamline data flow, improve quality, and reduce burden on sites.

Dr. Mats Sundgren (i-HD) will open with an overview of the eSource landscape and lessons from the cross-industry eSource Scale-Up Task Force.

Richard Yeatman (IgniteData) will offer the vendor perspective, sharing practical insights on enabling EHR-to-EDC using FHIR®-based interoperability.

Stephan Cichos (Bayer) will provide the sponsor view, highlighting real-world experience and value realized from implementation.

The session will conclude with a moderated panel discussion, exploring success factors, common challenges, and the path forward for scalable eSource adoption in oncology trials.

Learning Objectives:

• Understand the value and impact of eSource and EHR-to-EDC technologies in streamlining oncology clinical trial execution and reducing data duplication.
• Explore real-world implementation strategies from both vendor and sponsor perspectives, highlighting interoperability through FHIR® and lessons learned from early adopters.
• Identify key success factors and organizational readiness criteria necessary for scalable eSource adoption across clinical sites and trial sponsors.
• Gain practical insights from cross-industry collaboration, including outcomes from the i-HD eSource Scale-Up Task Force and guidance for future innovation in data-driven trial operations.